老有所依｜人均预期寿命将超越80岁大关！衰老终点如何改写？

Group 1 - The core objective is to increase China's average life expectancy to around 80 years by 2024, focusing on reducing mortality rates from major diseases, particularly cardiovascular diseases and cancer [1][3] - As of the end of 2024, the population aged 60 and above in China is expected to exceed 310 million, indicating a significant aging trend [1] - The development of innovative therapies and the application of new technologies, such as artificial intelligence, are essential to address the needs of the elderly population [1][7] Group 2 - Cancer is becoming a chronic disease, with advancements in medical technology and health levels contributing to increased life expectancy [3][4] - Eight provinces in China have already surpassed an average life expectancy of 80 years, with health indicators ranking among high-income countries [3] - The focus on immune system reconstruction is crucial for combating diseases like cancer, as highlighted by recent Nobel Prize-winning research [3] Group 3 - The burden of diseases such as lung and stomach cancer necessitates breakthroughs in tumor immunotherapy, positioning China as a key player in the precision immunotherapy era [4] - The development of early screening tools for cancer, particularly liver cancer, has shown promise in improving early diagnosis and treatment outcomes [5][8] - The five-year survival rate for liver cancer patients post-surgery has reached 71% due to advancements in treatment and follow-up care [5] Group 4 - AI and big data are being leveraged for disease management, emphasizing the importance of health management practices such as regular check-ups and early intervention for chronic diseases [7][9] - The integration of AI in cardiovascular disease management aims to enhance diagnosis and treatment through comprehensive patient data analysis [9][10] - The World Health Organization emphasizes the cost-effectiveness of expanding hypertension treatment coverage, which can be improved through digital health solutions [10] Group 5 - Regenerative medicine and stem cell research are gaining attention as potential solutions for age-related diseases, with the goal of improving both lifespan and quality of life [11][12] - The recent regulations on biomedical technology provide legal support for the development of cutting-edge medical technologies, including stem cell therapies [12] - The trend towards smart aging solutions is evident, with advanced technologies being integrated into elderly care to alleviate caregiver shortages [13][14]